Lv1
20 积分 2025-10-23 加入
A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally suppressed patients with chronic hepatitis B who are HBeAg-negative
5小时前
待确认
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
8个月前
已完结
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection
8个月前
已完结
皖公网安备34019202002308
